Novartis is growing in Latin America thanks to medicines like Voltaren and Diovan and markets like Brazil and Venezuela.
BY JOACHIM BAMRUD
Thanks to growing purchasing power and increased consciousness about health in Latin America, Swiss-based pharmaceutical giant Novartis is seeing strong growth in the region.
"2007 was good year for Novartis in Latin America and 2008 is so far panning out quite well," says Carlos Garcia, Latin American regional head for Novartis.
The company does not release Latin America revenue figures, but they grew by 11 percent last year, Garcia says.
Venezuela, its third-largest market in Latin America, is by far the fastest-growing one, measured in dollar terms. "The strongest growth – for the last 24 months – is Venezuela," Garcia says. "That is because they have high...
Keywords: Argentina, Brazil, Colombia, IMS, IPR, Latin American outlook, Mexico, talent, Venezuela